Working… Menu

A Safety Study of SGN-CD33A in AML Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01902329
Recruitment Status : Completed
First Posted : July 18, 2013
Last Update Posted : January 5, 2018
Information provided by (Responsible Party):
Seattle Genetics, Inc.